This Article  • References  • Full text PDF  • Correction  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (63)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

National High Blood Pressure Education Program Working Group

Arch Intern Med. 1996;156(17):1938-1947.

Abstract
To update 2 National High Blood Pressure Education Program working group reports on hypertension and chronic renal failure and renovascular hypertension, a working group was appointed by the director of the National Heart, Lung, and Blood Institute. Literature was searched through MEDLINE and the National Heart, Lung, and Blood Institute information center library. Scientific evidence was given precedence over clinical anecdotal experience. The working group members produced initial draft documents that were circulated to additional experts on hypertension and renal disease. This reiterative process occurred for 18 draft documents. The final report was sent to the representatives of the 44 organizations on the Coordinating Committee for vote and unanimously approved September 1, 1995. The report recommended treatment of hypertension to the goal of 130/85 mm Hg with whatever therapy is necessary to prevent the development of hypertensive nephrosclerosis or the progression of established renal disease of diverse causes. It seems reasonable to recommend angiotensin-converting enzyme inhibitors as initial therapy for patients with diabetes and microalbuminuria or overt diabetic nephropathy with and without hypertension. Renovascular disease has emerged as a major cause of end-stage renal disease, especially in the elderly. Newer screening procedures for the noninvasive screening of renovascular disease include the captopril test, renal scintigraphy following captopril administration, duplex scanning, and magnetic resonance angiography.

Arch Intern Med. 1996;156:1938-1947

Author Affiliations
From the National High Blood Pressure Education Program Working Group on Hypertension and Renal Disease, National Heart, Lung, and Blood Institute, Bethesda, Md. Members of the National High Blood Pressure Education Program Working Group are listed on page 1939.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Medicare Patients with Cardiovascular Disease Have a High Prevalence of Chronic Kidney Disease and a High Rate of Progression to End-Stage Renal Disease
McClellan et al.
J. Am. Soc. Nephrol. 2004;15:1912-1919.
ABSTRACT | FULL TEXT  

Role of Prostaglandin E Receptor EP1 Subtype in the Development of Renal Injury in Genetically Hypertensive Rats
Suganami et al.
Hypertension 2003;42:1183-1190.
ABSTRACT | FULL TEXT  

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
Chobanian et al.
Hypertension 2003;42:1206-1252.
ABSTRACT | FULL TEXT  

Compliance with Antihypertensive Therapy after Renal Artery Stenting
Reddy et al.
Biol Res Nurs 2003;5:37-46.
ABSTRACT  

Proven benefits of angiotensin receptor blockers in the progression of renal disease
Ruilope
Eur Heart J Suppl 2003;5:C9-C12.
ABSTRACT  

Effect of Blood Pressure Lowering and Antihypertensive Drug Class on Progression of Hypertensive Kidney Disease: Results From the AASK Trial
Wright et al.
JAMA 2002;288:2421-2431.
ABSTRACT | FULL TEXT  

Successful Blood Pressure Control in the African American Study of Kidney Disease and Hypertension
Wright et al.
Arch Intern Med 2002;162:1636-1643.
ABSTRACT | FULL TEXT  

Sodium Sensitivity of Blood Pressure Appearing Before Hypertension and Related to Histological Damage in Immunoglobulin A Nephropathy
Konishi et al.
Hypertension 2001;38:81-85.
ABSTRACT | FULL TEXT  

Temporary Treatment of Prepubescent Rats with Angiotensin Inhibitors Suppresses the Development of Hypertensive Nephrosclerosis
NAKAYA et al.
J. Am. Soc. Nephrol. 2001;12:659-666.
ABSTRACT | FULL TEXT  

Hypertension and Diabetes: New Therapeutic Options
Deedwania
Arch Intern Med 2000;160:1585-1594.
ABSTRACT | FULL TEXT  

Accuracy of Normal-Dose Contrast-Enhanced MR Angiography in Assessing Renal Artery Stenosis and Accessory Renal Artery Stenosis and Accessory Renal Arteries
Korst et al.
Am. J. Roentgenol. 2000;174:629-634.
ABSTRACT | FULL TEXT  

Current Strategies for Management of Hypertensive Renal Disease
Moore et al.
Arch Intern Med 1999;159:23-28.
ABSTRACT | FULL TEXT  

Diuretic-Based Treatment and Cardiovascular Events in Patients With Mild Renal Dysfunction Enrolled in the Systolic Hypertension in the Elderly Program
Pahor et al.
Arch Intern Med 1998;158:1340-1345.
ABSTRACT | FULL TEXT  

Renoprotective Effects of Felodipine and/or Enalapril in Spontaneously Hypertensive Rats With and Without L-NAME
Francischetti et al.
Hypertension 1998;31:795-801.
ABSTRACT | FULL TEXT  

The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
Arch Intern Med 1997;157:2413-2446.
ABSTRACT  

Effect of Calcium Channel or ß-Blockade on the Progression of Diabetic Nephropathy in African Americans
Bakris et al.
Hypertension 1997;29:744-750.
ABSTRACT | FULL TEXT